Skip to main content
. 2015 Dec;5(6):444–453. doi: 10.3978/j.issn.2223-3652.2015.11.03

Table 3. Association between clinical stage and echocardiographic anomalies.

WHO stages LV dilatation n [%] Systolic dysfunction n [%] Pericardial effusion n [%] Diastolic dysfunction n [%] Pulmonary hypertension n [%] LVH n [%] RV dilatation n [%]
Stage I (n=1) 0 0 0 0 1 [100] 0 1 [100]
Stage II (n=22) 0 0 3 [13.6] 8 [36] 0 1 [4.5] 14 [64]
Stage III (n=44) 0 0 6 [13.6] 12 [27] 4 [9.3] 6 [13.6] 37 [84]
Stage IV (n=33) 1 [3] 1 [3] 2 [6.0] 12 [36] 2 [6.3] 5 [15.2] 24 [72]
Total 1 [1] 1 [1] 11 [11] 32 [32] 7 [7] 12 [12] 76 [76]

WHO, World Health Organization; LVH, left ventriclar hypertrophy; RV, right ventricular.